COVID-19 disrupted delivery of essential health services globally - WHO

Related News survey has found that health services for noncommunicable diseases have been disrupted since the beginning of the coronavirus pandemic.

WHO Director-General, Tedros Ghebreyesus, said the results of the survey confirm reports that “we have been hearing from countries for a number of weeks now.” The Secretary to the Government of the Federation , Boss Mustapha, had said at a Presidential Task Force briefing in May that Nigeria has recorded more deaths from hospitals’ refusal to attend to patients with other illnesses than from COVID-19 virus.to treat patients for fear of contracting the COVID-19 virus.

In one in five countries, one of the main reasons for discontinuing services was a shortage of medicines, diagnostics and other technologies. Seventeen per cent of countries reporting have started to allocate additional funding from the government budget to include the provision of NCD services in their national COVID-19 plan.Encouraging findings of the survey were that alternative strategies have been established in most countries to support the people at highest risk to continue receiving treatment for NCDs, it stated.

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pyramax in clinical trial for COVID-19 treatment | The Guardian Nigeria News - Nigeria and World NewsPyramax, a World Health Organisation-approved antimalarial drug is under clinical trial in South Korean for the treatment of COVID-19. The drug manufacturer Shin Poong Pharmaceuticals first announced in April that Pyramax was effective against COVID-19. The announcement led to the appreciation of the company’s shares, Korean Biomedical Review said. COVID-19 was first detected in Wuhan, …
Source: GuardianNigeria - 🏆 1. / 94 Read more »

WHO resumes COVID-19 trial on hydroxychloroquine - HealthwiseLara Adejoro The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus says it will resume its trial of hydroxychloroquine. Ghebreyesus said during a press briefing on COVID-19 on Wednesday. The WHO had on May 25 suspended the clinical trials of hydroxychloroquine as COVID-19 treatment because of safety concerns. The WHO DG on Wednesday, however, … Let’s follow each other myself promise to follow back Confused elements, even more confused than one Baba from Daura I know This who are jus too confused...they said it cause more damage now they want to consider it again
Source: MobilePunch - 🏆 8. / 63 Read more »